BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33751804)

  • 1. Increased malignancies in our Waikato cohort of patients with systemic sclerosis.
    Rees MS; Frampton C; White DHN; Solanki KK
    Int J Rheum Dis; 2021 Apr; 24(4):555-561. PubMed ID: 33751804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancies associated with systemic sclerosis.
    Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
    Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
    Ooi C; Solanki K; Lao C; Frampton C; White D
    Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.
    Kamalaksha S; White DHN; Solanki KK
    Int J Rheum Dis; 2018 Jul; 21(7):1430-1435. PubMed ID: 29968328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis and malignancy.
    Sargin G; Senturk T; Cildag S
    Int J Rheum Dis; 2018 May; 21(5):1093-1097. PubMed ID: 29673080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
    Chang WS; Schollum J; White DH; Solanki KK
    Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.
    Pokeerbux MR; Giovannelli J; Dauchet L; Mouthon L; Agard C; Lega JC; Allanore Y; Jego P; Bienvenu B; Berthier S; Mekinian A; Hachulla E; Launay D
    Arthritis Res Ther; 2019 Apr; 21(1):86. PubMed ID: 30944015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
    Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
    Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.
    Kang KY; Yim HW; Kim IJ; Yoon JU; Ju JH; Kim HY; Park SH
    Scand J Rheumatol; 2009; 38(4):299-303. PubMed ID: 19308805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cohort study of cancer incidence in systemic sclerosis.
    Derk CT; Rasheed M; Artlett CM; Jimenez SA
    J Rheumatol; 2006 Jun; 33(6):1113-6. PubMed ID: 16622904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
    Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
    J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Antithyroid Antibodies in a New Zealand Cohort of Patients With Systemic Sclerosis.
    Solanki KK; Al-Majmuei M; White DHN
    J Clin Rheumatol; 2018 Aug; 24(5):264-271. PubMed ID: 29474198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis.
    Hashimoto A; Arinuma Y; Nagai T; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
    Intern Med; 2012; 51(13):1683-8. PubMed ID: 22790126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect health-related costs of systemic sclerosis in New Zealand.
    Padala SD; Lao C; Solanki K; White D
    Int J Rheum Dis; 2022 Dec; 25(12):1386-1394. PubMed ID: 36135601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
    Lazzaroni MG; Cavazzana I; Colombo E; Dobrota R; Hernandez J; Hesselstrand R; Varju C; Nagy G; Smith V; Caramaschi P; Riccieri V; Hachulla E; Balbir-Gurman A; Chatelus E; Romanowska-Próchnicka K; Araújo AC; Distler O; Allanore Y; Airò P;
    J Rheumatol; 2017 May; 44(5):639-647. PubMed ID: 28089973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature.
    Colaci M; Giuggioli D; Vacchi C; Lumetti F; Iachetta F; Marcheselli L; Federico M; Ferri C
    Autoimmun Rev; 2014 Feb; 13(2):132-7. PubMed ID: 24103404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancers in systemic sclerosis : risk factors, impact on survival and literature review].
    Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
    Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.